James Topper, Director at Sierra Oncology, holds 5.86M shares in Phathom Pharmaceuticals (Ticker: PHAT), holds 0.00 shares in Alpine Immune Sciences (Ticker: ALPN), holds 6.81M shares in NewAmsterdam Pharma Company (Ticker: NAMS).
James Topper latest transaction was an Uninformative Buy of ―.
What was James Topper's most profitable transaction?
James Topper’s most profitable transaction was an Informative Buy of SRRA stock on February 16, 2017. The return on the trade was 108.60%.
What is James Topper's role in Sierra Oncology?
James Topper's role in Sierra Oncology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.